In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer launches hostile bid for Warner-Lambert

Executive Summary

Shortly after Warner-Lambert announced it would merge with American Home Products, Pfizer launched a hostile bid for W-L, offering 2.5 shares of its common stock for each W-L share. Based on Pfizer's 10-day average of $39.35 the offer values Warner-Lambert at $84bn, a premium of (pr)26% to market. This is the largest hostile takeover attempt in history.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies